Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy
Clinical trial NCT02086487 · TERMINATED
Trial details
- NCT number
- NCT02086487
- Sponsor
- King Abdullah International Medical Research Center
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2016-08-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.